Mike Lee actually said...

Both this recoupment of investment and these profits are jeopardized by lawsuits that are filed by generics.

Proponents of the agreements have argued that the agreements can never properly be considered anti-competitive.

I agree with the holding of the Supreme Court.

But to assume that requires us to assume at the outset that the patent is, in fact, invalid.